Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Pfe crawled date : 2021 - 03 - 08 save search
Global Cell and Gene Therapy Market Report 2021-2027: Market Opportunities in Drug Approvals and Strong Pipeline & Increasing Number of Mergers and Acquisitions
Published: 2021-03-08 (Crawled : 13:14) - prnewswire.com
PFE A | $25.42 -1.05% -0.04% 44M
|
Health Technology
|
| O: 0.26%
H: 1.13%
C: -0.38%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: -0.02%
H: 0.89%
C: -0.31%
ORGO | $2.795 -2.27% -2.33% 330K
|
Finance
|
| O: 1.86%
H: 1.82%
C: -2.21%
AMGN | $264.07 -0.59% -0.59% 2.2M
|
Health Technology
|
| O: 0.15%
H: 1.81%
C: -0.12%
acquisition gene therapy therapy acquisitions drug merge approval gene therapies
Valneva and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccine Candidate
Published: 2021-03-08 (Crawled : 06:03) - globenewswire.com
PFE A | $25.42 -1.05% -0.04% 44M
|
Health Technology
|
| O: 0.26%
H: 1.13%
C: -0.38%
disease phase 2 vaccine
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.